Lethality of influenza virus enhanced by proteinNovember 14th, 2007 - 2:04 am ICT by admin
But the study, by Dr. Jonathan A. McCullers from the Department of Infectious Diseases at St. Jude Children’s Research Hospital in Memphis, Tennessee and colleagues, has provided key information on the disease.
The team understood the interaction between influenza viruses and bacteria by studying a newly discovered influenza A virus (IAV) protein, called PB1-F2. The gene encoding PB1-F2 is present in nearly all IAVs, including highly pathogenic avian IAVs that have infected humans and the IAV associated with the 1918 pandemic.
“PB1-F2 was recently shown to enhance viral pathogenicity in a mouse infection model, raising questions about its effects on the secondary bacterial infections associated with high levels of influenza morbidity and mortality,” explains Dr. McCullers.
The researchers found that expression of PB1-F2 increased the incidence of and exacerbated secondary bacterial pneumonia in a mouse model. Intranasal delivery of a synthetic peptide derived from a portion of PB1-F2 had the same effects.
Further, an influenza virus engineered to express a version of PB1-F2 identical to that in the 1918 pandemic strain was more virulent in mice and led to more severe bacterial pneumonia, explaining in part both the unparalleled virulence of the 1918 strain and the high incidence of fatal pneumonia during the pandemic.
According to Dr. McCullers, the finding that PB1-F2 promotes lung pathology in primary viral infection and secondary bacterial infection also provides critical information for the future.
“Given the importance of IAV as a leading cause of virus-induced morbidity and mortality year in and year out, and its potential to kill tens of millions in the inevitable pandemic that may have its genesis in the viruses currently circulating in southeast Asia, it is imperative to understand the role of PB1-F2 in IAV pathogenicity in humans and animals,” he says.
“These findings also reinforce the recent suggestion of the American Society for Microbiology that nations should stockpile antibiotics for the next pandemic, since many of the deaths during this event are likely to be caused by bacterial super-infections,” he adds.
The study is published in the October issue of the journal Cell Host and Microbe. (ANI)
- Viral infection likely to encourage pneumonia spread: Study - Apr 11, 2011
- Human, bird flu virus interaction can create more virulent strains - Feb 23, 2010
- H1N1 pandemic flu strain 'key to universal vaccine' - Jan 11, 2011
- Antibody that may help treat, prevent influenza outbreaks identified - Jul 09, 2010
- New oral spray effectively kills most of flu germs - Sep 10, 2012
- Avian flu virus wiping out baby seals - Aug 01, 2012
- 2009 H1N1 pandemic influenza vaccine protects mice from 1918 flu virus - Jun 16, 2010
- 1976 swine flu immunization might protect against pandemic H1N1 virus - Apr 24, 2010
- Soon, nasal spray vaccines to curb flu - Apr 12, 2011
- Pandemic flu virus may become resistant to Tamiflu - Mar 02, 2010
- Avian flu could lead to 1918-like Spanish flu pandemic - Feb 11, 2009
- Swine flu virus more dangerous than previously believed - Jul 14, 2009
- Exposure to seasonal flu made middle-aged prone to H1N1 - Dec 07, 2010
- Hyperactive immune system kills adults during pandemic flu - Dec 06, 2010
- Bacteria, not influenza, were real killers in 1918 flu pandemic - Aug 05, 2008
Tags: bacterial pneumonia, exacerbated, f2, fatal pneumonia, flu strain, iav, influenza virus, influenza viruses, intense scrutiny, intranasal, lethality, lung pathology, morbidity and mortality, pandemic, protein, secondary bacterial infections, synthetic peptide, viral pathogenicity, viruses and bacteria